Head and neck cancer (HNC) is a preventable malignancy that continues to cause substantial morbidity and mortality worldwide. Using data from the ARCAGE and Rome studies, we investigated the main predictors of survival after larynx, hypopharynx and oral cavity (OC) cancers. We used the Kaplan-Meier method to estimate overall survival, and Cox proportional models to examine the relationship between survival and sociodemographic and clinical characteristics. 604 larynx, 146 hypopharynx and 460 OC cancer cases were included in this study. Over a median follow-up time of 4.6 years, nearly 50% (n=586) of patients died. Five-year survival was 65% for larynx, 55% for OC, and 35% for hypopharynx cancers. In a multivariable analysis, we observed an increased mortality risk among older (≥71 years) vs. younger (≤50 years) patients with larynx/hypopharynx combined (LH) and OC cancers [HR=1.61, 95% CI 1.09-2.38 (LH) and HR=2.12, 95% CI 1.35-3.33 (OC)], current vs. never smokers [HR=2.67, 95% CI 1.40-5.08 (LH) and HR=2.16, 95% CI 1.32-3.54 (OC)], and advanced vs. early stage disease at diagnosis [IV vs. I, HR=2.60, 95% CI 1.78-3.79 (LH) and HR=3.17, 95% CI 2.05-4.89 (OC)]. Survival was not associated with sex, alcohol consumption, education, oral health, p16 expression, presence of HPV infection, or body mass index 2 years before cancer diagnosis. Despite advances in diagnosis and therapeutic modalities, survival after HNC remains low in Europe. In addition to the recognized prognostic effect of stage at diagnosis, smoking history and older age at diagnosis are important prognostic indicators for HNC. This article is protected by copyright. All rights reserved.

Abrahão, R., Anantharaman, D., Gaborieau, V., Abedi-Ardekani, B., Lagiou, P., Lagiou, A., Ahrens, W., Holcatova, I., Betka, J., Merletti, F., Richiardi, L., Kjaerheim, K., Serraino, D., Polesel, J., Simonato, L., Alemany, L., Agudo Trigueros, A., Macfarlane, T. V., Macfarlane, G. J., Znaor, A., Robinson, M., Canova, C., Conway, D. I., Wright, S., Healy, C. M., Toner, M., Cadoni, G., Boccia, S., Gheit, T., Tommasino, M., Scelo, G., Brennan, P., The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study, <<INTERNATIONAL JOURNAL OF CANCER>>, 2017; 2018 (6): N/A-N/A. [doi:10.1002/ijc.31294] [https://hdl.handle.net/10807/111818]

The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study

Lagiou, Pagona;Cadoni, Gabriella;Boccia, Stefania;Tommasino, Massimo;
2018

Abstract

Head and neck cancer (HNC) is a preventable malignancy that continues to cause substantial morbidity and mortality worldwide. Using data from the ARCAGE and Rome studies, we investigated the main predictors of survival after larynx, hypopharynx and oral cavity (OC) cancers. We used the Kaplan-Meier method to estimate overall survival, and Cox proportional models to examine the relationship between survival and sociodemographic and clinical characteristics. 604 larynx, 146 hypopharynx and 460 OC cancer cases were included in this study. Over a median follow-up time of 4.6 years, nearly 50% (n=586) of patients died. Five-year survival was 65% for larynx, 55% for OC, and 35% for hypopharynx cancers. In a multivariable analysis, we observed an increased mortality risk among older (≥71 years) vs. younger (≤50 years) patients with larynx/hypopharynx combined (LH) and OC cancers [HR=1.61, 95% CI 1.09-2.38 (LH) and HR=2.12, 95% CI 1.35-3.33 (OC)], current vs. never smokers [HR=2.67, 95% CI 1.40-5.08 (LH) and HR=2.16, 95% CI 1.32-3.54 (OC)], and advanced vs. early stage disease at diagnosis [IV vs. I, HR=2.60, 95% CI 1.78-3.79 (LH) and HR=3.17, 95% CI 2.05-4.89 (OC)]. Survival was not associated with sex, alcohol consumption, education, oral health, p16 expression, presence of HPV infection, or body mass index 2 years before cancer diagnosis. Despite advances in diagnosis and therapeutic modalities, survival after HNC remains low in Europe. In addition to the recognized prognostic effect of stage at diagnosis, smoking history and older age at diagnosis are important prognostic indicators for HNC. This article is protected by copyright. All rights reserved.
2018
Inglese
Abrahão, R., Anantharaman, D., Gaborieau, V., Abedi-Ardekani, B., Lagiou, P., Lagiou, A., Ahrens, W., Holcatova, I., Betka, J., Merletti, F., Richiardi, L., Kjaerheim, K., Serraino, D., Polesel, J., Simonato, L., Alemany, L., Agudo Trigueros, A., Macfarlane, T. V., Macfarlane, G. J., Znaor, A., Robinson, M., Canova, C., Conway, D. I., Wright, S., Healy, C. M., Toner, M., Cadoni, G., Boccia, S., Gheit, T., Tommasino, M., Scelo, G., Brennan, P., The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study, <<INTERNATIONAL JOURNAL OF CANCER>>, 2017; 2018 (6): N/A-N/A. [doi:10.1002/ijc.31294] [https://hdl.handle.net/10807/111818]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/111818
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 49
social impact